Updated Cost-effectiveness Analysis of Evolocumab in Patients With Very High-risk Atherosclerotic Cardiovascular Disease

Fonarow G, van Hout B, Villa G, Arellano J, Lindgren P


JAMA Cardiology, 2019;4(7):691-5
DOI:10.1001/jamacardio.2019.1647